Edgestream Partners, L.P.

Position in HRMY — Harmony Biosciences Holdings, Inc.

CIK 1535061 Princeton, NJ

Position in HRMY

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$6,681,271

+$2,812,250 QoQ

Shares Held

183,501

+32.8% QoQ

Ownership

0.315%

of shares outstanding

% of Portfolio

0.21%

of 13F equity value

Holder Rank

#53

of 319 holders

Holding Since

Jun 2023

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Edgestream Partners, L.P. holds $89,105,792 across 25 Biotechnology names. HRMY ranks #4 (7.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PCVX	Vaxcyte, Inc.	131,115	$7,621,714
2	EXEL	Exelixis, Inc.	132,163	$7,190,988
3	ACAD	Acadia Pharmaceuticals Inc	283,301	$7,167,515
4	HRMY	Harmony Biosciences Holdings, Inc. This page	183,501	$6,681,271
5	INVA	Innoviva, Inc.	269,348	$6,116,893
6	BMRN	Biomarin Pharmaceutical Inc	100,897	$5,773,326
7	NVAX	Novavax Inc	559,796	$5,273,278
8	IONS	Ionis Pharmaceuticals Inc	56,715	$4,496,932

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,681,271	183,501	+32.8%	Shares	Sole	2026-08-11
2026-03-31	$3,869,021	138,130	+52.1%	Shares	Sole	2026-05-18
2025-12-31	$3,398,746	90,827	+578.3%	Shares	Sole	2026-02-13
2025-09-30	$369,055	13,391	-82.3%	Shares	Sole	2025-11-12
2025-03-31	$2,514,806	75,770	+25.7%	Shares	Sole	2025-05-02
2024-03-31	$2,024,235	60,281	+23.2%	Shares	Sole	2024-05-10
2023-12-31	$1,580,923	48,945	+177.4%	Shares	Sole	2024-02-14
2023-09-30	$578,161	17,643	-64.0%	Shares	Sole	2023-11-15
2023-06-30	$1,726,843	49,072	—	Shares	Sole	2023-08-10
No filing history on record for this holder in this stock.